County
Boulder County Protocol Committee
Drugs and doses45
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate8
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 132 |
| Severe pain | adult | 1000 mg | PO | not captured | standing | page 132 |
| Severe pain | adult | 1000 mg | IV | not captured | standing | page 132 |
| Severe pain | peds | 15 mg/kg | PO | not captured | standing | page 132 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 12 mg | IV | not captured | standing | page 133 |
| SVT | peds | 0.2 mg/kg | IV | not captured | standing | page 133 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 135 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 135 |
| Hyperkalemia | adult | 2.5 mg | NEB | not captured | standing | page 135 |
| Hyperkalemia | peds | 2.5 mg | NEB | not captured | standing | page 135 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 135 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 135 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV | not captured | standing | page 138 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV | not captured | standing | page 138 |
| VF / pulseless VT | adult | 300 mg | IV | not captured | standing | page 138 |
| VF / pulseless VT | peds | 5 mg/kg | IV | not captured | standing | page 138 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 146 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 147 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 147 |
| Organophosphate poisoning | adult | 2 mg | IV/IM | not captured | standing | page 147 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IM | not captured | standing | page 147 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | pages 149, 150 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | pages 149, 150 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 149 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 149 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 149 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 3 g | IV/IO | not captured | standing | page 149 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 60 mg/kg | IV/IO | not captured | standing | page 149 |
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | page 149 |
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | page 149 |
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | page 149 |
D–F Dextrose, Diazepam, Diphenhydramine, Droperidol, Epinephrine, Fentanyl6
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 250 mL | IV/IO | not captured | standing | page 151 |
| Hypoglycemia | peds | 2 mL | PO | not captured | standing | page 151 |
| Hypoglycemia | peds | 5 mL | IV | not captured | standing | page 151 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 151 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV/IO | not captured | standing | page 153 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 153 |
| Procedural sedation | adult | 5 mg | IV/IO | not captured | standing | page 153 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 153 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 153 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 153 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25 mg | IV/IO/IM | not captured | standing | page 154 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 154 |
| Anaphylaxis | adult | 50 mg | IV/IO/IM | not captured | standing | page 154 |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 154 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 1.25 mg | IV/IO/IM | not captured | standing | page 141 |
| Other | adult | 5 mg | IV/IO/IM | not captured | standing | page 141 |
| Other | peds | 0.025 mg/kg | IV/IO/IM | not captured | standing | page 141 |
| Other | peds | 0.025 mg/kg | IV/IO/IM | not captured | standing | pages 141, 142 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.3 mg | IM | not captured | standing | page 157 |
| Allergic reaction | peds | 0.15 mg | IM | not captured | standing | page 157 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 157 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 157 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 157 |
| Other | adult | 0.3 mg | IM | not captured | standing | pages 157, 158 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | pages 157, 158 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.5–4 mcg/kg | IV/IO/IM/IN/NEB | not captured | standing | page 185 |
| Severe pain | peds | 1–2 mcg/kg | IV/IO/IM/IN/NEB | not captured | standing | page 185 |
G–L Glucagon, Haloperidol, Hydrocortisone, Hydromorphone, Hydroxocobalamin, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Lidocaine, Lorazepam11
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 160 |
| Hypoglycemia | peds | 0.5 mg | IM | not captured | standing | page 160 |
| Other | adult | 2 mg | IV | not captured | standing | page 160 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 160 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO/IM | not captured | standing | pages 142, 143 |
| Other | adult | 5 mg | IV/IO/IM | not captured | standing | pages 142, 143 |
| Other | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | pages 142, 143 |
| Other | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | pages 142, 143 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IM | not captured | standing | page 162 |
| Other | peds | 2 mg/kg | IV/IM | not captured | standing | page 162 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.5 mg | IV/IO/IM | not captured | standing | page 186 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | pages 163, 164 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | pages 163, 164 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 600 mg | PO | not captured | standing | page 183 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 183 |
| Severe pain | adult | 600 mg | PO | not captured | standing | page 183 |
| Severe pain | peds | 10 mg/kg | PO | not captured | standing | page 183 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 165 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 165 |
| Other | peds | 0.25 mg | NEB | not captured | standing | page 165 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1–0.3 mg/kg | IV/IO | not captured | standing | pages 166, 168 |
| Mild to moderate pain | adult | 0.5–1 mg/kg | IN | not captured | standing | pages 166, 168 |
| Mild to moderate pain | adult | 0.5 mg/kg | IM | not captured | standing | pages 166, 168 |
| Mild to moderate pain | peds | 0.1–0.3 mg/kg | IV/IO | not captured | standing | pages 166, 168 |
| Mild to moderate pain | peds | 0.5–1 mg/kg | IN | not captured | standing | pages 166, 168 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM | not captured | standing | pages 166, 168 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 15 mg | IV/IM | not captured | standing | page 183 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | page 169 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 169 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 138 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 138 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 138 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | IV/IO | not captured | standing | pages 171, 172 |
| Other | adult | 2 mg | IM/IN | not captured | standing | pages 171, 172 |
| Other | adult | 2 mg | IV/IO/IM | not captured | standing | pages 171, 172 |
| Other | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | pages 171, 172 |
| Other | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | pages 171, 172 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 171, 172 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | pages 171, 172 |
| Procedural sedation | adult | 0.5–2 mg | IV/IO/IM/IN | not captured | standing | page 171 |
| Procedural sedation | adult | 1 mg | IV/IO | not captured | standing | page 171 |
| Procedural sedation | adult | 2 mg | IM/IN | not captured | standing | pages 171, 172 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 171 |
| Procedural sedation | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 171, 172 |
| Seizure | adult | 4 mg | IV/IO/IM/IN | not captured | standing | pages 171, 172 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 171, 172 |
M–O Magnesium Sulfate, Methylprednisolone, Metoclopramide, Midazolam, Morphine, Naloxone, Nerve Agent Antidote Kit, Nitroglycerin, Olanzapine, Ondansetron, Oral Glucose11
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 174 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV | not captured | standing | page 174 |
| Eclampsia / pre-eclampsia | adult | 10 g | IM | not captured | standing | page 174 |
| Eclampsia / pre-eclampsia | adult | 2 g | IV/IO | not captured | standing | page 174 |
| Eclampsia / pre-eclampsia | adult | 5 g | IV/IO | not captured | standing | page 174 |
| Other | adult | 2 g | IV | not captured | standing | page 174 |
| Other | peds | 50 mg/kg | IV | not captured | standing | page 174 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO | not captured | standing | page 175 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO | not captured | standing | page 175 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO | not captured | standing | page 175 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO | not captured | standing | page 175 |
| COPD | adult | 125 mg | IV/IO | not captured | standing | page 175 |
| COPD | peds | 2 mg/kg | IV/IO | not captured | standing | page 175 |
| Other | adult | 125 mg | IV/IO | not captured | standing | page 175 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | page 175 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 10 mg | IV/IM | not captured | standing | page 139 |
| Nausea / vomiting | peds | 5 mg | IV/IM | not captured | standing | page 139 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 mg | IV/IO | not captured | standing | pages 177, 178 |
| Other | adult | 5 mg | IM/IN | not captured | standing | pages 177, 178 |
| Other | adult | 5 mg | IV/IO/IM | not captured | standing | pages 177, 178 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 177, 178 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 177, 178 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 177, 178 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | pages 177, 178 |
| Procedural sedation | adult | 1 mg | IM/IN | not captured | standing | page 177 |
| Procedural sedation | adult | 2 mg | IV/IO | not captured | standing | page 177 |
| Procedural sedation | adult | 5 mg | IM/IN | not captured | standing | page 177 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 177 |
| Procedural sedation | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 177 |
| Status epilepticus | adult | 10 mg | IM/IN | not captured | standing | pages 176, 177 |
| Status epilepticus | adult | 5 mg | IV/IO | not captured | standing | pages 176, 177 |
| Status epilepticus | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 176, 177 |
| Status epilepticus | peds | 0.2 mg/kg | IM/IN | not captured | standing | pages 176, 177 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–5 mg | IV | not captured | standing | page 186 |
| Severe pain | adult | 2–5 mg | IV/IO/IM/NEB | not captured | standing | page 186 |
| Severe pain | peds | 0.1 mg/kg | IV/IO/IM/NEB | not captured | standing | page 186 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 180 |
| Opioid overdose | peds | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 180 |
| Other | adult | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 180 |
| Other | peds | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 180 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 2.1 mg | IM | not captured | standing | pages 155, 156 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 182 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 182 |
Olanzapine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | PO/ODT | not captured | standing | pages 144, 145 |
| Other | adult | 10 mg | IV/IO/IM | not captured | standing | pages 144, 145 |
| Other | adult | 5 mg | IV/IO/IM | not captured | standing | pages 144, 145 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM/PO/ODT | not captured | standing | page 139 |
| Nausea / vomiting | peds | 2 mg | IV/IM/PO/ODT | not captured | standing | page 139 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | BUC | not captured | standing | page 187 |
| Hypoglycemia | peds | 0.3 g/kg | BUC | not captured | standing | page 187 |
P–R Phenylephrine, Pralidoxime, Promethazine, Proparacaine, Racemic Epinephrine5
Phenylephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | pages 96, 189 |
| Other | peds | 2 spray | IN | not captured | standing | pages 96, 189 |
| RSI induction | adult | 2 drop | IN | not captured | standing | pages 34, 189 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 1–2 g | IV/IO | not captured | standing | page 205 |
| Organophosphate poisoning | peds | 50 mg/kg | IV/IO | not captured | standing | page 205 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 6.25 mg | IV | not captured | standing | page 139 |
| Nausea / vomiting | peds | 0.25–0.5 mg/kg | IV | not captured | standing | page 139 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 drop | OPH | not captured | standing | page 192 |
| Other | peds | 2 drop | OPH | not captured | standing | page 192 |
| Mild to moderate pain | adult | 2 drop | OPH | not captured | standing | page 192 |
| Mild to moderate pain | peds | 2 drop | OPH | not captured | standing | page 192 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stridor | adult | 0.5 mL | NEB | not captured | standing | page 190 |
| Stridor | peds | 0.5 mL | NEB | not captured | standing | page 190 |
S–Z Sodium Bicarbonate, Tetracaine, Topical Ophthalmic Anesthetics, Tranexamic Acid4
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mEq/kg | IV/IO | not captured | standing | page 191 |
| Agitation | peds | 1 mEq/kg | IV/IO | not captured | standing | page 191 |
| Crush injury | adult | 1 mEq/kg | IV/IO | not captured | standing | page 191 |
| Crush injury | peds | 1 mEq/kg | IV/IO | not captured | standing | page 191 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 191 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 191 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 191 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 191 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 191 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 191 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 drop | OPH | not captured | standing | page 192 |
| Other | peds | 2 drop | OPH | not captured | standing | page 192 |
| Mild to moderate pain | adult | 2 drop | OPH | not captured | standing | page 192 |
| Mild to moderate pain | peds | 2 drop | OPH | not captured | standing | page 192 |
Topical Ophthalmic Anesthetics
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 drop | OPH | not captured | standing | page 192 |
| Other | peds | 2 drop | OPH | not captured | standing | page 192 |
| Mild to moderate pain | adult | 2 drop | OPH | not captured | standing | page 192 |
| Mild to moderate pain | peds | 2 drop | OPH | not captured | standing | page 192 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV/IO | not captured | standing | page 193 |
Cite this
Boulder County Protocol Committee, United States EMS Protocol Census. 186 dose entries, effective 2026-04-22.
https://protoquiz.com/census/agencies/boulder-county-ems/
The census is free and not for sale. Only public agencies are named.